Oklo stock jumps nearly 11% on new Buy coverage as nuclear trade wakes up again
29 January 2026
1 min read

Oklo stock jumps nearly 11% on new Buy coverage as nuclear trade wakes up again

New York, Jan 28, 2026, 21:21 EST — The market has closed.

  • Oklo ended the day 10.8% higher at $94.39, having reached $95.25 at one point.
  • Texas Capital Securities initiated coverage, setting a Buy rating and a price target of $138.
  • Traders are balancing renewed analyst optimism with the lengthy timeline required for new nuclear projects.

Oklo Inc. shares surged Wednesday following Texas Capital Securities’ initiation of coverage with a Buy rating, reigniting interest in the nuclear start-up. The stock finished 10.8% higher at $94.39. 1

This shift is significant as investors search for “always-on” power options to support data centers, putting nuclear back in the spotlight. Oklo remains in the build-and-permit phase and is driven more by story and funding risks than by immediate revenue prospects.

Washington is ramping up its focus on small reactors, which are promoted as faster to construct than conventional plants. This month, the U.S. Department of Energy handed out significant grants for small modular reactor projects, underscoring how policy shifts can rapidly sway sentiment in this sector. 2

Oklo has pushed to tie its narrative to big-load demand. Just earlier this month, the company teamed up with Meta, unveiling a deal to back 1.2 gigawatts of nuclear power in southern Ohio. 3

Texas Capital set a $138 price target, dubbing Oklo “the best investment vehicle for those bullish on advanced nuclear solutions.” The firm highlighted Oklo’s Aurora design — a sodium-cooled fast reactor that uses liquid sodium instead of water as a coolant. But the note also warned about the uneven setup: Oklo isn’t profitable yet, and its shares can swing widely. The stock’s moves hinge more on permitting, customer funding, and build milestones than on quarterly earnings. 4

Still, even the bulls are betting on a long timeline. New reactors require licenses, supply chains, and flawless construction—any delay could push back schedules and increase the risk of further dilution throughout the sector.

Traders will be watching the next session closely to see if Wednesday’s surge in volume and new coverage lead to sustained gains or if the stock slips back into a choppy trading range.

The initial challenge arrives Thursday morning (Jan. 29), as investors decide if the fresh $138 target will attract more buyers following the recent close-to-close surge.

Stock Market Today

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company projected about $200 billion in 2026 capital expenditures, triggering investor concern over AI spending. The stock had already dropped 11.5% after-hours Thursday. Amazon forecast Q1 net sales of $173.5–$178.5 billion and operating income of $16.5–$21.5 billion. Analyst Gil Luria downgraded Amazon, citing rising investment as its cloud lead narrows.
AMD stock jumps 8% in chip rebound — what investors are watching before Monday

AMD stock jumps 8% in chip rebound — what investors are watching before Monday

7 February 2026
AMD shares jumped 8.2% to $208.44 Friday, trading on heavy volume as chip stocks rebounded and the Dow closed above 50,000 for the first time. The Philadelphia Semiconductor Index rose 5.7% after Amazon’s AI spending plans lifted sector estimates. Nvidia’s CEO cited surging AI chip demand. AMD’s rally followed a weak revenue outlook earlier in the week.
Rivian stock slides toward $15 as Volkswagen software bet draws fresh scrutiny before Feb. 12 earnings
Previous Story

Rivian stock slides toward $15 as Volkswagen software bet draws fresh scrutiny before Feb. 12 earnings

Humana stock sinks again as Medicare Advantage rate shock keeps HUM under pressure
Next Story

Humana stock sinks again as Medicare Advantage rate shock keeps HUM under pressure

Go toTop